Rigorous Trial Design Is Essential to Understand the Role of Opioid Receptors in Ketamine's Antidepressant Effect
JAMA Psychiatry
.
2019 Jun 1;76(6):657-658.
doi: 10.1001/jamapsychiatry.2019.0766.
Authors
Boris D Heifets
1
,
Nolan R Williams
2
,
Brandon S Bentzley
2
,
Alan F Schatzberg
2
Affiliations
1
Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford, California.
2
Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California.
PMID:
31042274
DOI:
10.1001/jamapsychiatry.2019.0766
No abstract available
Publication types
Letter
Comment
MeSH terms
Alcoholism*
Antidepressive Agents
Depression
Humans
Ketamine*
Naltrexone
Receptors, Opioid
Substances
Antidepressive Agents
Receptors, Opioid
Naltrexone
Ketamine